Skip to main content


Medicolonia is dedicated to the treatment of cancer using immune-supportive therapies. The treatment consists of pro-healing therapies that support immune response and enhance other self-healing functions in the body.

Medicolonia Clinic

Our approach in the treatment of cancer consists of supporting the immune system using therapeutic fever (through total-body hyperthermia and local hyperthermia), immunotherapy, ozone therapy, the use of mistletoe and supportive nutrients. We also encourage patients to mobilize their own self-healing potential through a healthy lifestyle.

Concept and Treatment

The therapy is designed to restore and enhance immune function enabling the immune system to aggressively and effectively combat cancer cells throughout the body. All therapies are integrated in a schedule designed specifically for each individual patient. The treatment may involve some or all of the following therapies to optimize immune function or to directly destroy the cancer cells.

Dendritic cell therapy has no side effects for me, except for a touch of flu, which means that the treatment is catching on. It does cause a temporary fever, which usually starts about an hour after the injection. Over the course of eight hours, the fever rises a little, in my case up to about 39.5 C (102 F). Somehow it feels fine—I feel as though something positive is happening—I don’t feel ill. Although it’s a real fever, somehow my body knows that I need this. And the results are fantastic. My MRI scans over the past five years have confirmed that the treatment has been successful.
In my case, the dendritic cell therapy’s symptoms were minimal and lasted no more than two days. The hyperthermia was uncomfortable for me personally, but it only took three hours. There were no side effects from the treatment. After that I felt better and could do what I wanted. So the treatment did not exhaust me and because I was not exhausted, it was much easier to stay optimistic. Harmen Wagenmakers, long-time survivor of Stage IV bile duct cancer (cholangiocarcinoma) Harmen Wagenmakers, long-time survivor of Stage IV bile duct cancer (cholangiocarcinoma)